[144] Incyte Genomics Inc SEC Filing

Rhea-AI Filing Summary

Incyte Genomics' Form 144 discloses a proposed sale of 14,037 common shares with an aggregate market value of $1,122,969.83, to be sold through Morgan Stanley Smith Barney on 08/12/2025 on NASDAQ. The filing states these shares were acquired on 08/12/2025 through a stock option exercise and paid for in cash.

The notice also lists recent sales by BARRY FLANNELLY totaling 13,435 shares in July 2025, generating gross proceeds of $917,923.70. The filing shows 195,276,145 shares outstanding and includes the filer's certification that they do not possess undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Insider filed to sell 14,037 shares (~$1.12M); July dispositions totaled 13,435 shares (~$917.9k); impact appears limited relative to outstanding shares.

The Form 144 provides standard disclosure of a proposed sale, identifying the broker, share count, aggregate market value, and the fact the shares were acquired via stock option exercise and paid in cash. Recent July sales by the named seller are itemized with dates and gross proceeds. Taken together, these filings document insider liquidity actions but do not, by themselves, change the companys reported outstanding share count or financials in this notice.

Corporate Governance Expert

TL;DR: Filing shows compliance with Rule 144 and transparency on option exercise and subsequent sales; monitor for continued insider activity.

The document lists the broker and provides transaction-level details, including acquisition method (stock option exercise) and payment type (cash), which supports disclosure compliance. The filer also affirms no undisclosed material adverse information. The record of multiple sales over recent weeks is factual and warrants routine governance monitoring but is not presented here as a regulatory or disclosure failure.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	14037	1122969.83	195276145	08/12/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/12/2025	Stock Option Exercise	ISSUER			14037	08/12/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
BARRY FLANNELLY 1801 Augustine Cut-Off Wilmington DE 19803	Common	07/16/2025	1340	91602.40
BARRY FLANNELLY 1801 Augustine Cut-Off Wilmington DE 19803	Common	07/15/2025	1192	83273.12
BARRY FLANNELLY 1801 Augustine Cut-Off Wilmington DE 19803	Common	07/03/2025	2809	191435.60
BARRY FLANNELLY 1801 Augustine Cut-Off Wilmington DE 19803	Common	07/03/2025	8094	551612.58

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does INCY's Form 144 disclose?

The Form 144 discloses a proposed sale of 14,037 common shares valued at $1,122,969.83, to be sold on 08/12/2025 via Morgan Stanley Smith Barney on NASDAQ.

How were the 14,037 INCY shares acquired?

According to the filing, the shares were acquired on 08/12/2025 through a stock option exercise and payment was made in cash.

Has the insider sold INCY shares recently?

Yes. The filing lists sales by BARRY FLANNELLY in July 2025 totaling 13,435 shares with gross proceeds of $917,923.70.

What is the company's reported share count in this notice?

The filing shows 195,276,145 shares outstanding.

Does the filer state any undisclosed material information?

The filer certifies by signing the notice that they do not know of any material adverse information about the issuer that has not been publicly disclosed.